NCT07766213

Brief Summary

This observational cross-sectional study aims to determine chronic pain phenotypes in individuals with multiple sclerosis (MS) and to investigate the clinical characteristics associated with different pain phenotypes. Participants with MS and chronic pain will undergo a comprehensive clinical assessment to identify nociceptive, neuropathic, nociplastic, and mixed pain phenotypes. The assessment will include clinical history, pain characteristics and distribution, quantitative sensory testing, pain intensity, disease severity, fatigue, health-related quality of life, and pain catastrophizing. The clinical characteristics of participants with different pain phenotypes will subsequently be compared.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
13mo left

Started Aug 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 14, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

August 15, 2026

Expected
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2027

Last Updated

August 14, 2026

Status Verified

August 1, 2026

Enrollment Period

10 months

First QC Date

August 11, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

CHRONIC PAINNEUROPATHIC PAINNOCIPLASTIC PAINMULTIPLE SCLEROSIS

Outcome Measures

Primary Outcomes (6)

  • Quantitative sensory test: static tactile mechanical threshold

    Von Frey Monofilaments (2 gr- 26 gr) will be used assessment for the static tactile mechanical detection threshold.

    10 minutes

  • Quantitative sensory test: hot-cold pain threshold

    Coins will be used for the hot-cold pain threshold. The cold sensing test will be done with a coin held at room temperature. The hot sensing test will be done in the form of a coin placed in the pocket and applied to the participant after waiting for 30 minutes.

    5 minutes

  • Quantitative sensory test: static mechanical allodynia

    A digital algometer device (JTech) will be used for static mechanical allodynia (pressure pain threshold). In the device, the pain sensation will be tested by applying 4 kg of pressure to the participant.

    5 minutes

  • Quantitative sensory test: dynamic mechanical allodynia

    A soft brush will be used for dynamic mechanical allodynia. The brush will be gently moved over the skin at a speed of 3-5 cm per second in a fixed direction over the patients primary painful area.

    5 minutes

  • Quantitative sensory test: vibration sense

    128 Hz tuning fork will be used in vibration assessment. The device will be applied over the bony prominences in the painful area of the patient.

    5 minutes

  • Margolis Pain Diagram

    The Margolis Pain Diagram, consists of a dorsal and a ventral drawing body, is used to assess the location and distribution of the pain \[20\]. Participants will ask to point out the place where they experience pain during the preceding 4 weeks for at least 24 hours.

    1 minute

Secondary Outcomes (8)

  • Numeric Pain Rating Scale

    1 minute

  • Pain Catastrophizing Scale (PCS)

    5 minutes

  • Modified Fatigue Impact Scale (MFIS)

    1 minute

  • Health-Related Quality of Life

    5 minutes

  • Multiple Sclerosis Disease Severity

    5 minutes

  • +3 more secondary outcomes

Interventions

A current clinical algorithm will be used to determine the predominant type of pain in individuals with MS. The classification to diagnose nociceptive, neuropathic and nociplastic pain will based on a recent method developed by Nijs et al. This method consists of seven steps in total. These steps question the following, respectively: duration of pain, pain distribution, presence of nociceptive pain, presence of neuropathic pain, phenomenon of hypersensitivity, presence of hypersensitization and presence of specific comorbidity. Besides, inter-rater and intra-rater reliability of pain classification algorithm will be determined by two independent researchers.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants meeting the inclusion criteria will be taken for this cross-sectional study. Individuals with MS who apply to Kutahya Health Sciences University Hospital Physiotherapy Department will be screened for eligibility by their clinic physicians and will then be asked to participate in this study.

You may qualify if:

  • Age 18 years or older
  • Definite diagnosis of multiple sclerosis according to the McDonald criteria
  • No MS relapse or high-dose steroid treatment within the previous 3 months
  • Pain intensity ≥2 on the Numeric Rating Scale in at least one body region for at least 3 months
  • Ability to read, understand, and communicate in Turkish

You may not qualify if:

  • Pregnancy
  • Severe psychiatric disorder and/or severe cognitive impairment confirmed by a neurologist or neuropsychiatrist
  • Presence of a serious pathology or disease that may compromise the assessment process or affect clinical decision-making, including metastasis, cancer, untreated or unhealed fractures, neurological disorders other than multiple sclerosis, or a history of diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Sciences University Physical Medicine and Rehabilitation Department

Kütahya, Turkiye, 43100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Multiple SclerosisChronic PainNeuralgiaNociplastic Pain

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPeripheral Nervous System DiseasesNeuromuscular Diseases

Central Study Contacts

Nisa TURUTGEN, Msc.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

August 11, 2026

First Posted

August 14, 2026

Study Start (Estimated)

August 15, 2026

Primary Completion (Estimated)

June 15, 2027

Study Completion (Estimated)

September 15, 2027

Last Updated

August 14, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations